EAA Chapter France
The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.
EAA's Chapter France is focusing on the national implementation of EU HTA and consequences for the various stakeholders in the French national context.
Convention of EAA Chapter France
A multi-stakeholder glance into the initial EU HTA Assessments from the French Perspective
Preliminary Agenda*
September 18th, 2026 at Université Paris Cité
9:30 AM - 12:30 PM:
Plenary Sessions 1 & 2: Status of EU HTA - Process Focus; moderated by Étienne Lengliné & Jörg Ruof
Keynote presentations by Francis Megerlin, Diane Lastennet, Lionel Collet Laure Guéroult-Accolas, Jean-Yves Blay & others
13:30 PM - 15:30 PM:
Plenary Session 3: Methodological & Clinical Focus; moderated by Bruno Falissard & Jean-François Bergmann
Keynote presentations by Bruno Falissard, Gilles Vassal, Vincent Laugel, Nicolas Girard, Jean-Yves Pierga & others
Please note: Meeting language is French, with possible English contributions.
* Agenda, speakers and times are subject to change
EAA's Chapter France is funded by AstraZeneca SAS, Novartis Pharma SAS, Roche SAS,
hosted by Université Paris Cité and supported by leem.